Elite Pharmaceuticals Inc
ELTP- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001053369
In the last 90 days, Elite Pharmaceuticals Inc insiders filed 1 open-market purchase and 0 sales; 1 institution reported holding it in 13F filings for Q2 2026, worth $365 in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Elite Pharmaceuticals Inc changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 1 | 2 | +1 |
| Shares | 5.18K | 5.68K | +500 (+9.6%) |
| Value | $3.79K | $3.64K | −$156 (−4.1%) |
New holders (1)
Institutions that held Elite Pharmaceuticals Inc at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Wall Street Access Asset Management, LLC | 500 | $320 | 0.00% |
Sold out (0)
Institutions that held Elite Pharmaceuticals Inc at the end of Q2 2025 and filed for Q3 2025 without it.
None.